Understanding Sabcs 2024 Immunotherapy
If you are looking for information about Sabcs 2024 Immunotherapy, you have come to the right place. This Educational Session took place at 3:30 p.m. on Thursday, Dec. 12,
Key Takeaways about Sabcs 2024 Immunotherapy
- This session took place at 5:30 p.m. Thursday, Dec. 12,
- This session took place at 2 p.m. Wednesday, Dec. 11,
- Virginia Kaklamani, MD, UT Health San Antonio, San Antonio, TX, mentions the key highlights from the San Antonio Breast ...
- This session took place at 2 p.m. Wednesday, Dec. 11,
- Virginia Kaklamani, MD, UT Health San Antonio, provides updates on
Detailed Analysis of Sabcs 2024 Immunotherapy
Gaia Griguolo, MD, University of Padova, Padova, Italy, highlights the Phase III AFT-38 PATINA trial (NCT02947685) which ... This session occurred at 7 a.m. Wednesday, Dec. 11, This session took place at 12:30 p.m. on Friday, Dec. 13,
This Plenary Lecture was given at 8:30 a.m. Friday, Dec. 13,
We hope this detailed breakdown of Sabcs 2024 Immunotherapy was helpful.
